BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17876901)

  • 1. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
    Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
    World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions associated with oxaliplatin.
    Saif MW
    Expert Opin Drug Saf; 2006 Sep; 5(5):687-94. PubMed ID: 16907658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
    Syrigou E; Syrigos K; Saif MW
    Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Thomas RR; Quinn MG; Schuler B; Grem JL
    Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
    Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
    J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity Reactions to oxaliplatin: incidence and management.
    Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
    Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant hypersensitivity reaction (HSR) presented with persistent dry cough after receiving oxaliplatin in a pancreatic cancer patient.
    Li J; Peccerillo J; Kaley K; Saif MW
    Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):165-8. PubMed ID: 20124609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
    Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
    Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
    Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
    JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.
    Bano N; Najam R; Qazi F; Mateen A
    Asian Pac J Cancer Prev; 2016; 17(4):1637-41. PubMed ID: 27221832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.
    Park SJ; Lee KY; Park WS; Min SY
    Oncology; 2013; 85(6):323-7. PubMed ID: 24247529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.
    Kidera Y; Satoh T; Ueda S; Okamoto W; Okamoto I; Fumita S; Yonesaka K; Hayashi H; Makimura C; Okamoto K; Kiyota H; Tsurutani J; Miyazaki M; Yoshinaga M; Fujiwara K; Yamazoe Y; Moriyama K; Tsubaki M; Chiba Y; Nishida S; Nakagawa K
    Int J Clin Oncol; 2011 Jun; 16(3):244-9. PubMed ID: 21243395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to oxaliplatin in two asian patients.
    Ng CV
    Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-induced fever and release of IL-6.
    Ulrich-Pur H; Penz M; Fiebiger WC; Schüll B; Kornek GV; Scheithauer W; Raderer M
    Oncology; 2000 Sep; 59(3):187-9. PubMed ID: 11053984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions associated with oxaliplatin and their clinical management.
    Toki MI; Saif MW; Syrigos KN
    Expert Opin Drug Saf; 2014 Nov; 13(11):1545-54. PubMed ID: 25307143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.